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Roger Valine, the insurer agreed to discontinue its policy "to avoid long and expensive litigation with the Justice Department
that could easily have cost thousands and
maybe millions in legal fees."

U

RECENT MEETINGS

At its October 14 meeting, the Board
unanimously accepted DCA's recommendation to abolish its existing Examination
Committee made up of non-Board members, and to reestablish the Examination
Committee as an integral part of the Board
with a member of the Board serving as
chair of the Committee.
At the Board's December 1-2 meeting,
President John Anthony, OD, announced
that he will be appointing a Sunset Review
Committee to prepare the Board for its upcoming "sunset" review before the legislature; SB 2036 (McCorquodale) (Chapter
908, Statutes of 1994) created a sunset review process for occupational licensing
boards within DCA, requiring each to be
comprehensively reviewed every four years.
SB 2036 imposes an initial sunset date of
July 1, 1999 for the Board; approximately
one year prior to the Board's sunset date,
a Joint Legislative Sunset Review Committee will review the Board's performance in several areas and make a recommendation to the legislature on whether
the Board should be abolished, restructured, or redirected in terms of its statutory
authority and priorities. The legislature
may then either allow the sunset date to
pass (in which case the Board would cease
to exist and its powers and duties would
transfer to DCA) or pass legislation extending the sunset date for another four
years. [14:4 CRLR 89]
Also in December, the Board reviewed
the request of Akom, Inc., for approval of
its product, AK-T-caine, as a topical pharmaceutical agent (TPA) which may be used
by optometrists in their examination of patients in California. Following discussion,
the Board agreed to approve the product and
to (1) seek the Medical Board's approval as
required by Business and Professions Code
section 3041(e), and (2) schedule rulemaking hearings to amend section 1560, Title 16
of the CCR, to add AK-T-caine to the list of
approved TPAs in California.
Also at the December meeting, the
Board re-elected John Anthony, OD, to
serve as president, and selected Robert
Dager, OD, as vice-president and Mona
Tawatao as secretary for 1995.
* FUTURE MEETINGS
March 9-10 in Sacramento.
May 22-23 in San Francisco.
August 24-25 in Sacramento.
December 1-2 in Orange County.

BOARD OF PHARMACY
Executive Officer: PatriciaHarris
(916) 445-5014

p

ursuant to Business and Professions

Code section 4000 et seq., the Board
of Pharmacy grants licenses and permits
to pharmacists, pharmacies, drug manufacturers, wholesalers, and sellers of hypodermic needles. It regulates all sales of
dangerous drugs, controlled substances,
and poisons. The Board is authorized to
adopt regulations, which are codified in
Division 17, Title 16 of the California
Code of Regulations (CCR). To enforce its
regulations, the Board employs full-time
inspectors who investigate complaints received by the Board. Investigations may
be conducted openly or covertly as the
situation demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized by
law to suspend or revoke licenses or permits for a variety of reasons, including
professional misconduct and any acts substantially related to the practice of pharmacy.
The Board consists of ten members,
three of whom are nonlicensees. The remaining members are pharmacists, five of
whom must be active practitioners. All are
appointed for four-year terms.
In January 1994, public member Herb
Stoecklein resigned from the Board; at
this writing, he has not yet been replaced.

* MAJOR PROJECTS
Board Publishes Scaled-Back Version of Citation and Fine Regulations.
On November 4, the Board republished
notice of its intent to adopt new Article
9.5, commencing with section 1775, to
Title 16 of the CCR. For years, the Business and Professions Code has authorized
the Board to adopt regulations to implement a system of issuing citations and
fines to its licensees and to others who
unlawfully provide services for which a
license is required; however, the Board
has never implemented this authority.
Currently, when a licensee fails to comply
with a statute or regulation, the Board is
limited to seeking suspension, revocation,
license probation, or judicial relief through
actions by the Attorney General or a district
attorney to enforce compliance. These
processes are time-consuming, expensive,
and allow illegal activities to continue
throughout the process. In addition, many
violations of laws regulating the practice
of pharmacy do not warrant such severe
discipline. These regulations, if adopted,
would establish a citation and fine program to deal with some of these violations.

The proposed regulations represent an extremely scaled-back version ofthe citation
and fine regulations proposed by the
Board in 1993. [14:4 CRLR 91-92; 14:2&3
CRLR 95; 14:1 CRLR 73]
Proposed new section 1775 would provide that a Board inspector or committee
may issue citations containing orders of
abatement and/or fines for violations of
the statutes referred to in section 1775.1.
Each citation must be in writing and must
describe the nature and facts of the violation, including a reference to the statute or
regulation alleged to have been violated,
and the citation must be served upon the
individual personally or by certified mail.
Section 1775 would also require that a
citation inform the person or entity that if
a hearing to contest the finding of a violation is desired, the hearing must be requested by written notice to the Board
within thirty days of the issuance of the
citation.
Proposed new section 1775.1 would
list the Business and Professions Code
violations for which the Board inspector
or committee may issue a citation and fine
or order of abatement. At this time, the
listed sections which justify the issuance
of a citation and/or fine pertain only to the
unlicensed practice of pharmacy or related
activities and violation of the pharmacist's
duty to provide oral consultations before
dispensing medication.
Section 1775.2 would set forth the criteria which must be considered when determining the amount of an administrative
fine (when a fine is assessed with a citation). As proposed, this regulation provides that in no event shall the fine exceed
$2,500 for violations of the Code sections
set forth in section 1775.1; a Board inspector or committee, in his/her/its discretion,
may issue an order to cease the violation
without charging a fine. In assessing the
amount of an administrative fine, section
1775.2 would require the Board inspector
or committee to consider, among other
things, the gravity of the violation, the
good or bad faith of the cited person or
entity, the history of previous violations,
evidence that the violation was or was not
willful, and the extent to which the cited
person or entity has mitigated or attempted to mitigate any damage or injury
caused by the violation.
New section 1775.3, as proposed, would
provide that an order of abatement shall
either be personally served or mailed by
certified mail; the time allowed for the
correction of a violation begins when the
order of abatement is final and has been
served or received. If a cited person or
entity who has been issued an order of
abatement is unable to complete the cor-
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rection in the time given because of condition beyond his/her/its control after the
exercise of reasonable diligence, the person or entity may request an extension of
time to complete the correction; such a
request must be in writing and made
within the time set forth for abatement.
Failure to comply with an order of abatement shall constitute grounds for revocation or suspension of the license, permit,
or registration. This section would also
provide that the failure of a person or
entity cited to pay a fine within thirty days
of the date of assessment, unless the citation is being appealed, may result in disciplinary action by the Board; when a citation is not contested and a fine is not
paid, the full amount of the fine shall be
added to the fee for renewal of the license
and the license shall not be renewed without payment of the renewal fee and fine.
Proposed new section 1775.4 would
provide that any person or entity served
with a citation may contest the citation by
appealing to the Board in writing within
thirty days of the issuance of the citation.
In addition to requesting a hearing as provided in Business and Professions Code
section 125.9, the person or entity may
also request an office conference within
fourteen calendar days after service of a
citation; the office conference would be
conducted by the Board's Executive Officer, a supervising inspector, or Board
member(s). The person or entity may have
legal counsel or an authorized representative present at the office conference. At the
conclusion of the office conference, the
Executive Officer, supervising inspector,
or Board member(s) may affirm, modify,
or dismiss the citation, including any fine
or order of abatement issued; the reasons
for the action must be stated in writing and
a copy must be served or sent by certified
mail to the person or entity cited within
fourteen calendar days of the date of the
office conference. The decision shall be
deemed a final order with regard to the
citation issued. The right to request a hearing to contest a citation is not waived by
requesting an office conference after which
the citation is affirmed; if the citation is
dismissed at the office conference, the request for a hearing will be deemed withdrawn. If the citation is modified at the office
conference, the citation originally issued
shall be deemed withdrawn and a new citation issued; a request for a hearing on the
subsequent citation shall be made within
thirty days of the subsequent issuance.
At this writing, the Board is scheduled
to hold a public hearing on the proposed
adoption of new sections 1775, 1775.1,
1775.2, 1775.3, and 1775.4 on January 25
in Los Angeles.

Fee Increases Proposed. Also on November 4, the Board published notice of
its intent to amend sections 1749 and
1793.5, Title 16 of the CCR, which specify
the schedule of fees and penalties for the
licenses, permits, and registrations issued
by the Board. The proposed amendments
would increase specified fees to ensure
that the Board's reserve fund is restored
and maintained at a prudent level for conducting ongoing operations. Currently,
Business and Professions Code section
4415(r) directs the Board to maintain a
reserve fund equal to approximately one
year's worth of operating expenditures;
however, fiscal policy in the Department
of Finance has identified three months'
worth of operating expenditures as the
appropriate amount to be maintained as a
reserve fund. A fiscal analysis of the
Board's current reserve, its expected income from fees at current levels, and the
Board's expectation of increased expenditures for consumer awareness programs,
recent increases in staff, and the continuing efforts toward automation indicates
that by the end of fiscal year 1995-96, the
Board will have a budget deficit of $797,064,
which will grow to $2.2 million by the end
of fiscal year 1996-97. Consequently, the
Board has proposed to increase its fees
beginning July 1, 1995 to protect its reserve fund.
The amendments to section 1749 would,
among other things, increase the fee for
the issuance of a permit to conduct a pharmacy from $340 to $400; increase the
annual permit renewal fee from $175 to
$250; increase the penalty for failure to
renew from $87.50 to $125; and increase
the fee for the biennial renewal of a pharmacist's license from $115 to $150. The
amendments to section 1793.5 would increase the fee for registration as a pharmacy technician from $25 to $50. Although these changes would eliminate the
danger of a deficit in the Board's reserve
fund, the increased income will not provide the Board with a reserve equal to
three months' operating expenditures; accordingly, the Board may sponsor legislation which would allow it to impose further fee increases.
At this writing, the Board is scheduled
to hold a public hearing on the proposed
amendments to sections 1749 and 1793.5
on January 25 in Los Angeles.
Electronic Transmission of Prescriptions. AB 1807 (Bronshvag) (Chapter 26,
Statutes of 1994) revised the definition of
the term "prescription" to include prescriptions for controlled substances that
are electronically transmitted, and specified the information gathering and storage
requirements for a valid prescription
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transmitted electronically. [14:4 CRLR 89;
14:2&3 CRLR 98] However, the Board's
existing regulations do not contain the
provisions necessary to implement these
amendments. On November 4, the Board
published notice of its intent to add new
section 1717.4, Title 16 of the CCR, to
authorize the electronic transmission of
prescriptions by prescribers to pharmacies
while assuring the security and confidentiality of electronically transmitted prescriptions.
As proposed, this regulation would
provide that, except as otherwise prohibited by law, prescriptions may be transmitted by electronic means from the prescriber to the pharmacy. An electronically
transmitted prescription shall include the
name and address of the prescriber, a telephone number for verbal confirmation,
date of transmission, and the identity of
the recipient, as well as any other information required by federal or state law. An
electronically transmitted prescription
shall be transmitted only to the pharmacy
of the patient's choice; the pharmacy receiving the electronic transmission must
either receive or have the capacity to retrieve the prescription in hard copy form;
and any hard copy of a prescription shall
be maintained on paper of permanent
quality. The regulation also provides for
an "interim storage device," which is an
electronic file into which a prescription is
entered for later retrieval by an authorized
individual; any interim storage device
shall record and maintain the date of entry
and/or receipt of the prescription order,
date of transmission from the interim storage device, and identity of the recipient of
such transmission, as well as other specified information. The interim storage device must be maintained so as to prevent
unauthorized access and use of prescription information, including dispensing information. The regulation would further
require that any person who transmits,
maintains, or receives any prescription or
prescription refill orally, in writing, or
electronically shall ensure the security, integrity, and confidentiality of the prescription and any information contained
therein.
At its October meeting, Deputy Attorney General William Marcus again discussed the extremely complex overlap between state and federal law on the issue of
electronic prescription transmission. [14:4
CRLR 90] He noted that even though electronic transmission of prescriptions would
be allowed if this regulation takes effect,
a triplicate form signed by the prescriber
is still necessary for prescriptions for
Schedule II controlled substances, according to California state law. Where an inter&
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mediate health care facility, licensed
skilled nursing facility, or licensed home
health agency is involved, a triplicate form
must be prepared by the pharmacy prior to
dispensing (except in certain limited circumstances). If there is only a partial filling of a prescription, the pharmacy must
prepare a triplicate form and have it signed
by the person receiving the drugs at the
facility for each partial filling.
At this writing, the Board is scheduled
to hold a public hearing on the proposed
addition of section 1717.4 on January 25
in Los Angeles.
Automation of the Triplicate Program.
The Board's Oversight Committee on the
Automation of the Triplicate Program met
several times throughout the fall to discuss
the progress of the study being carried out
to develop a way to implement an automated statewide monitoring system for
tracking controlled substance prescriptions as an alternative to the current paperintensive triplicate system. [14:4 CRLR
90] The goal of the automation study is to
have an online, real-time system containing 100% of the triplicate prescription information on record and current so that it
may be accessed by prescribers, pharmacies, and eventually others such as regulatory boards. The study has involved interviews of various individuals and organizations as well as the consideration of
other electronic monitoring systems in place
in Oklahoma and Hawaii and the Statewide
Integrated Narcotics System (SINS) used in
California and other states to monitor narcotics. The Feasibility Study Report (FSR) that
will summarize the study's findings was to
be completed by December 1 and finalized
by February 1995. However, due to a delay
in completing the draft FSR, the January 4,
1995 meeting of the Oversight Committee
to discuss the draft was cancelled; the meeting will be rescheduled as soon as the draft
is completed. Copies of the draft FSR will
be made available to interested parties prior
to the meeting.
Rulemaking Update. The following
is a status report on Board rulemaking
proposals discussed in previous issues of
the Reporter.
- After its adoption of new sections
1751.11 and 1751.12,Title 16oftheCCR,
in May 1994, the Board submitted the
rulemaking file to the Department of Consumer Affairs (DCA). Section 1751.11
would establish a list of dangerous drugs
which may be furnished by a pharmacist
to a home health agency or licensed hospice and stored in transportable, tamperproof, sealed storage containers; it would
also create inventory and recordkeeping
requirements. Section 1751.12 would provide that a pharmacy shall not issue porta16

ble containers unless the home health
agency or licensed hospice complies with
the provisions of section 1751.11. [14:4
CRLR 91; 14:2&3 CRLR 95-96; 14:1 CRLR
73] DCA approved the proposed regulations on December 9, and forwarded them
to the Office of Administrative Law (OAL)
on December 19; at this writing, the regulations are still awaiting approval by OAL.
* In November, DCA approved the
Board's proposed amendments to section
1724, Title 16 of the CCR, which would
require candidates taking the California
pharmacist licensure examination to pass
both sections of the exam (essay and multiple choice) at the same time; a candidate
who fails the multiple choice section of the
exam will be given a failing grade for the
entire exam and will have to take the entire
exam again at another time. This change
was made to streamline the examination
and grading process by reducing the time
and cost for expert graders and travel expenses. [14:4 CRLR 91; 14:2&3 CRLR 96;
14:1 CRLR 74] On December 5, OAL approved the changes, which become effective on February 1, 1995 and will apply to
the California pharmacist licensure examination in June.
- At its October 24 meeting, the Board
resumed its discussion of proposed amendments to section 1707.2, Title 16 of the
CCR, which would apply the same requirements and standards for oral consultation to out-of-state pharmacies which
ship, mail, or deliver prescriptions to California residents as are applied to in-state
pharmacies. As proposed, the regulation
would provide, among other things, that
any resident or non-resident pharmacy
that ships, mails, or delivers any controlled substances or dangerous drugs or
devices shall make a reasonable attempt to
contact the patient or his/her agent and
provide oral consultation over the telephone. The regulation would also specify
alternatives to oral consultation over the
telephone before dispensing the medication in cases where the patient cannot be
reached for oral consultation and further
attempts would cause unnecessary delay in
the patient receiving the medication; such
alternative written consultations must notify the patient of his/her right to an oral
consultation and must include directions
for use and storage and any precautions
and relevant warnings. [14:4CRLR90-91;
14:2&3 CRL 95]
At the October meeting, the Board
stated that it has received many comments
supporting and opposing the proposed
changes and, as a result, unanimously decided to delay adoption of the amendments until 1995 to allow for further study
and discussion of all information. Al-

though most Board members support the
concept of the amendments because of
their importance to consumer safety, they
also want to discuss the issue further with
mail-order company representatives; as a
result, the Board directed Executive Officer Patricia Harris to arrange a meeting
with mail-order representatives. DCA also
announced plans to host an open forum for
the Board and those concerned about consultation by out-of-state pharmacies to
continue discussion on the issue of consultation requirements; the forum is a public
meeting but will involve about two dozen
"major stakeholders" participating in a
discussion of the issues, problems, and
solutions. At this writing, the forumwhich will be facilitated by Rob Eskridge
of Growth Management Center USA-is
scheduled for February 9 in Sacramento.
*

LEGISLATION
Future Legislation. At its October
meeting, the Board agreed to sponsor
three legislative changes during 1995; at
this writing, however, the Board has not
yet found authors for any of the proposals.
The first proposal approved by the
Board would amend Business and Professions Code section 4085, which specifies
the requirements an individual must meet
in order to be licensed by the Board. The
amendment would repeal a part of the
section describing qualifications of foreign-educated applicants; according to the
Board, it no longer uses this provision to
qualify such applicants for the California
pharmacist licensure examination. Currently, the statute provides that an applicant who was a nonresident of the United
States for at least five of the ten years prior
to enrollment in a foreign pharmacy school,
and who has graduated from a foreign
pharmacy school, must have either successfully completed coursework established by the Board as being equivalent to
that required for domestic graduates, or
received a grade satisfactory to the Board
on an examination designed to measure
the equivalency of foreign pharmacy education with that required of domestic graduates in order to be registered as a pharmacist. The proposed legislative amendment would repeal the first option and
instead provide that if the applicant has
graduated from a foreign pharmacy school,
he/she also must have received a satisfactory grade on an examination designed to
measure the equivalency of foreign pharmacy education with that required of domestic graduates. The Board has recognized only the latter option, which requires that foreign graduates take and pass
the Foreign Pharmacy Graduate Equivalency Examination, since March 1992.
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The Board also agreed to pursue an
amendment to Business and Professions
Code section 4052, in order to allow recognized schools of nursing to obtain dangerous drugs and devices needed for training. Existing statutory law contains no
specific provision authorizing provision
of dangerous drugs and devices to nursing
schools for training purposes. Currently,
the Board's supervising inspectors approve "orders for use" for nursing schools
to obtain dangerous drugs and devices;
however, the Board would like to add a
statutory provision to allow schools of
nursing recognized as training facilities by
the Board of Registered Nursing to obtain
dangerous drugs and devices, not including controlled substances, for training purposes.
The Board will also seek to add new
section 4227.4 to the Business and Professions Code in order to provide statutory
authority that would implement Title 21,
Code of Federal Regulations, section
1301.28, which permits controlled substances to be provided to the masters of
ocean vessels so long as "such activity is
authorized by state law...." In the past,
pharmacies have furnished controlled and
non-controlled dangerous drugs to ocean
vessels under the condition that the drugs
were delivered in a sealed container on
board the vessel and the container could
not be opened until the vessel entered
international waters; however, there is no
provision in state law authorizing this
practice. The proposed section would permit a pharmacy or wholesaler to furnish
dangerous drugs to a master or first officer
of an ocean vessel pursuant to a written
requisition; the dangerous drugs would
have to be delivered in a sealed container,
and the wholesalers or pharmacies engaging in such activities would be required to
give notice to the Board within thirty days
of undertaking such activity.

*

RECENT MEETINGS

At its October 23-25 meeting, the
Board completed its strategic planning
sessions with facilitator Michael Dues by
finalizing its purpose, vision, goals, and
objectives for the next five years. [14:4
CRLR 93] According to its mission statement, the purpose of the Board is to protect the health, safety, and welfare of the
people of California with integrity and
honesty; advocate the highest quality of
affordable pharmaceutical care; and promote education, wellness, and quality of
life. The Board identified nine general
areas in which it has established goals,
including enhancing the role of the pharmacist, communication and public education, advocacy, standards of practice, con-

sultant education, automation, customer
service, enforcement, and disciplinary
guidelines. Within each of these goal
areas, the Board further established specific objectives to pursue in the next five
years; at the end of the session, the Board
adopted the goals and mission statement.
Also at the October meeting, the Board
briefly discussed the funding of its proposed "Ask Your Pharmacist" public education program, which would inform consumers about the benefits of the new oral
consultation requirement. [14:4 CRLR 94]
Although the Board submitted a budget
change proposal to fund the program, the
Department of Finance disapproved it. Thus,
the program would have to be funded via a
fee increase; however, the Board's current
proposal to increase fees is required to
maintain the Board's reserve fund. As a
result, the consumer education program is
effectively on hold until the Board's funding issues are resolved.
Also in October, the Board again discussed the issue of prescription drug sample distribution. [14:4 CRLR 93-94] Deputy Attorney General William Marcus clarified that restrictions on the distribution and
possession of drug samples would require
legislative action; the Board could seek authority to do anything from restricting drug
sampling to banning it altogether. The
Board considered a motion to seek legislation to ban the distribution of drug samples; however, the vote was divided with
four Board members in favor of the motion, three against, and one abstaining.
The four members who did not vote in
favor of the motion felt there should be
more discussion about the advantages of
samples, the use of "starter packs" which
are not defined as samples, and the items
which could be used to replace samples.
The Board agreed to convene an informational session on this issue.
Also in October, the Board approved
the closure of its Los Angeles branch office to take place on January 1, 1995; the
Board's decision was based on its establishment of a strong administrative component and a complaint unit in Sacramento, the consolidation of the probation
monitoring and interim committee meeting processing into the Sacramento office,
and the imminent ability of all inspectors
to use computer modems to send documents and itineraries to and from the Sacramento office. Only one office assistant
and one secretary position will be moved
to the Sacramento office; all inspector and
supervising inspector positions will remain in southern California as field positions. The Los Angeles telephone number
will be routed to Sacramento and the
Board hopes to establish an 800 number
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for consumers to call with complaints.
Hearings of the Southern Interim Committee (SIC), which handles disciplinary matters in southern California, will continue
to be held in southern California so that
practitioners and inspectors required to
appear are not inconvenienced; meetings
of the SIC and office conferences for inspectors will be held at some public site to
be selected or possibly at the offices of
another state agency, such as the Medical
Board, which is willing to occasionally
share its facilities.
Also at the October meeting, the Board
discussed a letter from the California Retailers Association (CRA) regarding the
growing problem of prescription illegibility; the letter described how illegible prescriptions cause pharmacists to spend excessive time deciphering them and are
sometimes the cause of mistakes in the
dispensing of medications. The letter referred to an American Medical Association report recognizing this issue and requested the Pharmacy Board and the Medical Board to address the problem of prescription legibility. CRA suggested that
the Board adopt a requirement that prescriptions be typed or printed; however,
the Board noted that such a requirement
could only be created by legislation and
opined that such a step may not be necessary. The Board acknowledged the problem and directed Executive Officer Patricia Harris to contact the Medical Board
and the Board of Dental Examiners in
order to seek solutions to this issue.
0
FUTURE MEETINGS
January 25-26 in Los Angeles.
March 29-30 in Sacramento.
May 24-25 in Sacramento.
July 26-27 in San Diego.
October 25-26 in San Francisco.

BOARD OF
REGISTRATION FOR
PROFESSIONAL
ENGINEERS AND
LAND SURVEYORS
Executive Officer:
Harold L. Turner
(916) 263-2222

T

he Board of Registration for Professional Engineers and Land Surveyors
(PELS) regulates the practice of engineering and land surveying through its administration of the Professional Engineers Act,
sections 6700 through 6799 of the Business
and Professions Code, and the Profes8'

